These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 24992040)
1. The role of CXCR3 in DSS-induced colitis. Chami B; Yeung AW; van Vreden C; King NJ; Bao S PLoS One; 2014; 9(7):e101622. PubMed ID: 24992040 [TBL] [Abstract][Full Text] [Related]
2. CXCL10+ T cells and NK cells assist in the recruitment and activation of CXCR3+ and CXCL11+ leukocytes during Mycobacteria-enhanced colitis. Singh UP; Singh R; Singh S; Karls RK; Quinn FD; Taub DD; Lillard JW BMC Immunol; 2008 Jun; 9():25. PubMed ID: 18533024 [TBL] [Abstract][Full Text] [Related]
3. The simultaneous blockade of chemokine receptors CCR2, CCR5 and CXCR3 by a non-peptide chemokine receptor antagonist protects mice from dextran sodium sulfate-mediated colitis. Tokuyama H; Ueha S; Kurachi M; Matsushima K; Moriyasu F; Blumberg RS; Kakimi K Int Immunol; 2005 Aug; 17(8):1023-34. PubMed ID: 16000328 [TBL] [Abstract][Full Text] [Related]
4. Type I interferons have opposing effects during the emergence and recovery phases of colitis. Rauch I; Hainzl E; Rosebrock F; Heider S; Schwab C; Berry D; Stoiber D; Wagner M; Schleper C; Loy A; Urich T; Müller M; Strobl B; Kenner L; Decker T Eur J Immunol; 2014 Sep; 44(9):2749-60. PubMed ID: 24975266 [TBL] [Abstract][Full Text] [Related]
5. Involvement of IL-17A in the pathogenesis of DSS-induced colitis in mice. Ito R; Kita M; Shin-Ya M; Kishida T; Urano A; Takada R; Sakagami J; Imanishi J; Iwakura Y; Okanoue T; Yoshikawa T; Kataoka K; Mazda O Biochem Biophys Res Commun; 2008 Dec; 377(1):12-6. PubMed ID: 18796297 [TBL] [Abstract][Full Text] [Related]
6. Macrophagic HDAC3 inhibition ameliorates Dextran Sulfate Sodium induced inflammatory bowel disease through GBP5-NLRP3 pathway. Che N; Zhang Y; Zhang S; Kong X; Zhang Y; Wang S; Yuan Z; Liao Y Int J Med Sci; 2024; 21(8):1385-1398. PubMed ID: 38903915 [TBL] [Abstract][Full Text] [Related]
7. Cux1 transcription factor is induced in inflammatory bowel disease and protects against experimental colitis. Darsigny M; St-Jean S; Boudreau F Inflamm Bowel Dis; 2010 Oct; 16(10):1739-50. PubMed ID: 20848487 [TBL] [Abstract][Full Text] [Related]
8. MD-1 deficiency attenuates dextran sodium sulfate (DSS)-induced colitis through modulating the function of colonic lamina propria dendritic cells. Pan H; Zhang G; Zhang L; Wang W; Shang J; Wang X; Zhao Q; Li J Mol Immunol; 2016 Jul; 75():1-10. PubMed ID: 27209086 [TBL] [Abstract][Full Text] [Related]
9. MANF ameliorates DSS-induced mouse colitis via restricting Ly6C Yang L; Shen WW; Shao W; Zhao Q; Pang GZ; Yang Y; Tao XF; Zhang WP; Mei Q; Shen YX Acta Pharmacol Sin; 2023 Jun; 44(6):1175-1190. PubMed ID: 36635421 [TBL] [Abstract][Full Text] [Related]
10. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium. Pedersen G Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335 [TBL] [Abstract][Full Text] [Related]
11. GPR65 (TDAG8) inhibits intestinal inflammation and colitis-associated colorectal cancer development in experimental mouse models. Marie MA; Sanderlin EJ; Satturwar S; Hong H; Lertpiriyapong K; Donthi D; Yang LV Biochim Biophys Acta Mol Basis Dis; 2022 Jan; 1868(1):166288. PubMed ID: 34628032 [TBL] [Abstract][Full Text] [Related]
12. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing. Kasper SH; Spalinger MR; Leonardi I; Gerstgrasser A; Raselli T; Gottier C; Atrott K; Frey-Wagner I; Fischbeck-Terhalle A; Rogler G; Scharl M Digestion; 2016; 93(4):249-59. PubMed ID: 27115526 [TBL] [Abstract][Full Text] [Related]
13. The oxysterol receptor LXRβ protects against DSS- and TNBS-induced colitis in mice. Jakobsson T; Vedin LL; Hassan T; Venteclef N; Greco D; D'Amato M; Treuter E; Gustafsson JÅ; Steffensen KR Mucosal Immunol; 2014 Nov; 7(6):1416-28. PubMed ID: 24803164 [TBL] [Abstract][Full Text] [Related]
14. FGL2 regulates IKK/NF-κB signaling in intestinal epithelial cells and lamina propria dendritic cells to attenuate dextran sulfate sodium-induced colitis. Li T; Chen RR; Gong HP; Wang BF; Wu XX; Chen YQ; Huang ZM Mol Immunol; 2020 Jan; 117():84-93. PubMed ID: 31743856 [TBL] [Abstract][Full Text] [Related]
16. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action. Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725 [TBL] [Abstract][Full Text] [Related]
17. MicroRNA-21 knockout improve the survival rate in DSS induced fatal colitis through protecting against inflammation and tissue injury. Shi C; Liang Y; Yang J; Xia Y; Chen H; Han H; Yang Y; Wu W; Gao R; Qin H PLoS One; 2013; 8(6):e66814. PubMed ID: 23826144 [TBL] [Abstract][Full Text] [Related]
18. Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22. Jofra T; Galvani G; Cosorich I; De Giorgi L; Annoni A; Vecchione A; Sorini C; Falcone M; Fousteri G Clin Exp Immunol; 2019 Sep; 197(3):263-275. PubMed ID: 31194881 [TBL] [Abstract][Full Text] [Related]